FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


10679 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Pupil constriction Constricted pupil
Pupil dilation Dilated pupil
membrana pupillaris i vänster öga Pupillary membrane
membrana pupillaris i höger öga Pupillary membrane
Pur-In-Mix insulin adverse reaction Insulin adverse reaction
Pur-In-Mix insulin allergy Allergy to insulin
Purified protein derivative Product containing tuberculin purified protein derivative (medicinal product)
Purified protein derivative Product containing tuberculin purified protein derivative (medicinal product)
Purpose of radiotherapy Radiation oncology AND/OR radiotherapy
syfte med strålbehandling Radiation oncology AND/OR radiotherapy
Pustular Pustule
Putrescine Putrescine
Pyemotes tritici Pyemotes ventricosus (organism)
antiinflammatoriskt medel med pyrazolderivat Pyrazole derivative
pyridostigminbromid 60 mg/5 ml, sirap Product containing precisely pyridostigmine bromide 12 milligram/1 milliliter conventional release oral solution (clinical drug)
pyridoxinberoendesyndrom Pyridoxine-dependent epilepsy (disorder)
pyridoxinpreparatallergi Allergy to pyridoxine (finding)
Pyrophosphotransferase Pyrophosphotransferase
Pyrrhura hypoxantha Pyrrhura molinae subspecies molinae (organism)
Pyrroline-5-carboxylate reductase deficiency Deficiency of pyrroline-5-carboxylate reductase
Q-T interval QT interval feature
Quadricoccus australiensis Quatrionicoccus australiensis (organism)
kinaprilallergi Non-allergic hypersensitivity to quinapril (finding)
Quinapril hydrochloride Product containing quinapril (medicinal product)
Quinidine gluconate 324mg Product containing only quinidine in oral dose form (medicinal product form)
kinidinglukonat 324 mg , tablett med modifierad frisättning Product containing only quinidine in oral dose form (medicinal product form)
kinidinglukonat 324 mg, depåtablett Product containing only quinidine in oral dose form (medicinal product form)
kinidinsulfat 300 mg, tablett med modifierad frisättning Product containing only quinidine in oral dose form (medicinal product form)
kinidinsulfat 300 mg, depåtablett Product containing only quinidine in oral dose form (medicinal product form)
kinindihydroklorid 300 mg/ml, infusionsvätska, lösning, ampull 1 ml Product containing precisely quinine dihydrochloride 300 milligram/1 milliliter conventional release solution for injection (clinical drug)
kininhydroklorid 300 mg/ml, infusionsvätska, lösning, ampull 2 ml Quinine 300 mg/mL solution for injection
R1 phenotype CDe haplotype (finding)
R2 phenotype cDE haplotype (finding)
RBC color/staining NOS Red blood cell colour
RBC colour/staining NOS Red blood cell colour
RETIRED Concepts Inactive value (foundation metadata concept)
antihumant T-lymfocytglobulin från kanin 25 mg, pulver och vätska till injektionslösning, flaska Rabbit anti-human T-lymphocyte globulin 25 mg powder for solution for injection vial
Racemase Racemase
Radiation therapy Radiation oncology AND/OR radiotherapy
Radical neurolysis Destruction - action
Radiculitis Radiculitis
Radionuclide dacryocystography Radionuclide lacrimal flow study
planering av strålbehandling med magnetresonanstomografi Magnetic resonance imaging for radiotherapy planning
Radiotherapy purpose - NOS Radiation oncology AND/OR radiotherapy
Radiotherapy purpose - NOS Radiation oncology AND/OR radiotherapy
Railroading Action
Ralstonia Ralstonia
Ralstonia eutropha Wautersia eutropha (organism)
Ramadiers operation Drainage of petrous apex of mastoid
pericementitis fibrosa-syndrom med förgrening Periodontal disease
ramiprilallergi Non-allergic hypersensitivity to ramipril
ramucirumab 10 mg/ml, injektionsvätska, lösning Product containing only ramucirumab (medicinal product)
ramucirumab10 mg/ml, vätska för intravenös infusion, lösning Product containing only ramucirumab (medicinal product)
Rancho-skalan - nivåer för kognitiv funktion Rancho Los Amigos Levels of Cognitive Functioning Scale (assessment scale)
Range of motion exercise Range of motion exercise
ranibizumab 10 mg/ml, vätska för intravitreal injektion, flaska 0,05 ml Product containing precisely ranibizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
syndrom efter våldtäktstrauma Post-trauma response
syndrom efter våldtäktstrauma: sammansatt reaktion Post-trauma response
syndrom efter våldtäktstrauma: tyst reaktion Post-trauma response
snabbt progredierande parodontit Aggressive periodontitis
rasburikas 7,5 mg, pulver för beredning av infusionsvätska Product containing precisely rasburicase 7.5 milligram/1 vial powder for conventional release solution for injection (clinical drug)
rasburikas 7,5 mg, pulver och vätska till infusionsvätska Product containing precisely rasburicase 7.5 milligram/1 vial powder for conventional release solution for injection (clinical drug)
reaktiva cellulära förändringar i samband med intrauterint preventivmedel Reactive cellular changes caused by intrauterine contraceptive device (finding)
potential för förbättrad stresshantering i samhälle Ready for enhanced community coping
Reason not stated concept Outdated component (foundation metadata concept)
Reattachment of retina by photocoagulation Repair of retina for retinal detachment by photocoagulation
Recent Recent
Recessive congenital ichthyosiform erythroderma Trichothiodystrophy (disorder)
Recomb human follicle stim horm alpha 1200iu inj pdr+diluent Pituitary follicle stimulating hormone 1200 unit powder for solution for injection vial
rekombinant humant follikelstimulerande hormon 1 200 IE, pulver och vätska till injektionslösning Pituitary follicle stimulating hormone 1200 unit powder for solution for injection vial
rekombinant alfaglukosidas 50 mg, pulver till injektionsvätska, flaska Product containing only alpha-glucosidase (medicinal product)
rekombinant antihemofilifaktorpreparat, 1 000 IE, injektionsvätska, lösning, flaska 1 ml Antihemophilic factor agent only product
rekombinant antihemofilifaktorpreparat, 1 000 IE pulver till injektionsvätska, flaska Antihemophilic factor agent only product
rekombinant antihemofilifaktorpreparat, 1 500 IE, injektionsvätska, lösning, flaska 1 ml Antihemophilic factor agent only product
rekombinant antihemofilifaktorpreparat, 1 500 IE, pulver till injektionsvätska, flaska Antihemophilic factor agent only product
rekombinant antihemofilifaktorpreparat, 2 000 IE, injektionsvätska, lösning, flaska 1 ml Antihemophilic factor agent only product
rekombinant antihemofilifaktorpreparat, 2 000 IE, pulver till injektionsvätska, flaska Antihemophilic factor agent only product
rekombinant antihemofilifaktorpreparat, 250 IE, injektionsvätska, lösning, flaska 1 ml Antihemophilic factor agent only product
rekombinant antihemofilifaktorpreparat, 250 IE, pulver till injektionsvätska, flaska Octocog alfa 250 international unit powder for solution for injection vial
rekombinant antihemofilifaktorpreparat, 3 000 IE, injektionsvätska, lösning, flaska Antihemophilic factor agent only product
rekombinant antihemofilifaktorpreparat, 500 IE, injektionsvätska, lösning, flaska 1 ml Antihemophilic factor agent only product
rekombinant antihemofilifaktorpreparat, 500 IE, pulver till injektionsvätska, flaska Product containing precisely octocog alfa 500 international unit/1 vial powder for conventional release solution for injection (clinical drug)
rekombinant koagulationsfaktor IX , 1 000 IE, pulver och vätska till injektionslösning, flaska Product containing only nonacog alfa (medicinal product)
rekombinant koagulationsfaktor IX 1 000 IE, pulver till injektionsvätska, lösning, flaska Product containing only nonacog alfa (medicinal product)
rekombinant koagulationsfaktor IX, 1 000 IE, pulver till injektionsvätska, flaska Nonacog alfa 1000 international unit powder for solution for injection vial
rekombinant koagulationsfaktor IX , 250 IE, pulver och vätska till injektionslösning, flaska Product containing only nonacog alfa (medicinal product)
rekombinant koagulationsfaktor IX 250 IE, pulver till injektionsvätska, lösning, flaska Product containing only nonacog alfa (medicinal product)
rekombinant koagulationsfaktor IX, 250 IE, pulver till injektionsvätska, flaska Nonacog alfa 250 international unit powder for solution for injection vial
rekombinant koagulationsfaktor IX , 500 IE, pulver och vätska till injektionslösning, flaska Product containing only nonacog alfa (medicinal product)
rekombinant koagulationsfaktor IX 500 IE, pulver till injektionsvätska, lösning, flaska Product containing only nonacog alfa (medicinal product)
rekombinant koagulationsfaktor IX , 500 IE, pulver till injektionsvätska, flaska Nonacog alfa 500 international unit powder for solution for injection vial
rekombinant koagulationsfaktor VIIa , 120 000 IE, pulver och vätska till injektionslösning, flaska Coagulation factor VIIa only product in parenteral dose form
rekombinant koagulationsfaktor VIIa 120 000 IE, pulver till injektionsvätska, lösning, flaska Coagulation factor VIIa only product in parenteral dose form
rekombinant koagulationsfaktor VIIa , 240 000 IE, pulver och vätska till injektionslösning, flaska Coagulation factor VIIa only product in parenteral dose form
rekombinant koagulationsfaktor VIIa 240 000 IE, pulver till injektionsvätska, lösning, flaska Coagulation factor VIIa only product in parenteral dose form
rekombinant koagulationsfaktor VIIa , 60 000 IE, pulver och vätska till injektionslösning, flaska Coagulation factor VIIa only product in parenteral dose form
rekombinant koagulationsfaktor VIIa 60 000 IE, pulver till injektionsvätska, flaska Coagulation factor VIIa only product in parenteral dose form
rekombinant humant follikelstimulerande hormon alfa 150 IE/lutropin alfa 75 IE, pulver och vätska till injektionslösning, flaska Product containing only follitropin alfa and lutropin alfa (medicinal product)
rekombinant humant follikelstimulerande hormon alfa 1 050 IE, pulver för beredning av injektionsvätska Product containing only follitropin alfa (medicinal product)
rekombinant humant follikelstimulerande hormon alfa 1 050 IE, pulver för beredning av injektionsvätska + spädningsvätska Product containing only follitropin alfa (medicinal product)
rekombinant humant follikelstimulerande hormon alfa 150 IE, pulver och vätska till injektionslösning, ampull Follitropin alfa 300 unit/mL solution for injection

Start Previous Page 77 of 107 Next End


Reference Sets

Reference set descriptor

Back to Start